| |||||||||||||
|
星期二, 5月 02, 2017
藏紅花圈徵公益項目 5/12 截止
Baker-Polito Administration Kicks Off Small Business Month
Baker-Polito Administration Kicks Off Small Business Month
Engagement sessions to gather feedback on opportunities for further growth and development in small business sector
BOSTON – Today in Worcester, the Baker-Polito Administration officially proclaimed May as Small Business Month and kicked off the first of ten listening sessions focused on engaging small businesses to discuss ways Massachusetts can encourage economic growth and job creation.
“Small businesses account for close to half of our state’s employment and our administration will continue to advance policies and partnerships to support our local economy,” said Governor Charlie Baker. “We welcome this opportunity to further engage the small business community on ideas to drive new growth and job creation.”
Lieutenant Governor Karyn Polito and Housing and Economic Development Secretary Jay Ash joined local leaders and small business stakeholders at Clark University to share resources, hear concerns and present a proclamation recognizing May as Small Business Month. Listening sessions will inform the economic development strategy of the Executive Office of Housing and Economic Development.
“The contributions of small businesses extend beyond the number of jobs they create and serve as a backbone of every region, downtown and community in Massachusetts,” said Lieutenant Governor Karyn Polito. “We look forward to highlighting existing resources available to small businesses and soliciting further ideas through listening sessions across the state.”
“Last year, Governor Baker signed our Economic Development Bill, which provides up to $1 billion in new investments for our citizens, communities and businesses,” said Housing and Economic Development Secretary Jay Ash. “This legislation created a robust set of tools for economic development, and we are looking to create continuous engagement with our small business community to collaborate on how to best support this critical sector of the Massachusetts’ economy.”
“These listening sessions give us the opportunity to discuss the complex issues that our small businesses face, from access to capital to navigating state resources,” said Assistant Secretary for Business Development Nam Pham. “Through conversations with stakeholders and local leaders, we hope to identify the challenges in each region of the Commonwealth and build strategies to expand opportunities for our small businesses.”
The Executive Office of Housing and Economic Development and the Office of Business Development will hold ten listening sessions across Massachusetts:
Tuesday, May 2 Kick-off event with Lieutenant Governor Polito
Clark University, Worcester, MA at 7:30 a.m.
Thursday, May 4: Cape Cod with Deputy Secretary Carolyn Kirk
Chatham Community Center, Chatham, MA at 5:30 p.m.
Tuesday, May 9: Western Mass with Secretary Jay Ash
Holyoke Community College, Holyoke, MA at 6:00 p.m.
Wednesday, May 10: Berkshire County with Secretary Jay Ash
Berkshire Community College, Pittsfield, MA at 7:30 a.m.
Monday, May 15: Northeast with Deputy Secretary Carolyn Kirk
Salem State University, Salem, MA at 7:30 a.m.
Tuesday, May 16: South Coast with Assistant Secretary Juan Vega
Bristol Community College, Fall River, MA at 7:30 a.m.
Wednesday, May 17: Brockton with Lieutenant Governor Polito
The Conference Center at Massasoit, Brockton, MA at 1:30 p.m.
Tuesday, May 23: MetroWest with Secretary Jay Ash
The Center for Arts Natick (TCAN), Natick, MA at 7:30 a.m.
Thursday, May 25: North Central with Secretary Jay Ash
Mount Wachusett Community College, Gardner, MA at 7:30 a.m.
Wednesday, May 31: Boston
MassChallenge, 21 Drydock Ave, Boston, MA at 5:30 p.m.
美国南加州华裔非营利组织需要规范专业运营 确保可持续发展
轉載:
美国南加州华裔非营利组织需要规范专业运营 确保可持续发展
美国加州华裔众议员周本立Ed Chau在选区内的蒙特利公园市举办“非营利组织NPO工作坊”，来自南加州地区各族裔非营利组织代表近50人参加了当天工作坊。参加工作坊的华裔非营利组织代表表示，非营利组织规范和专业运营，方可确保非营利组织的持续发展。
当天的工作坊，周本立邀请来了自加州政府特许经营税务局、加州非营利组织协会、公共辩护律师机构的专业人士，为非营利组织和准备成立非营利组织的代表，讲解如何申请成立非营利组织、非营利组织如何向加州政府和联邦政府进行年度财务状况申报，如何进行募款、在运营非营利组织过程中的合法运营等专题介绍。
据周本立介绍，目前加州有近8万个非营利组织，在加州是排名在零售业和制造业后的第三大行业。 但是，加州有很多关于非营利组织的条例，非营利组织不一定完全了解。
周本立表示，非营利组织在为我们加州社区提供的各类服务中具有非常重要的作用。主办这个工作坊，希望工作坊可以为非营利组织提供行业趋势、最佳运营实务，以及交流平台。
加州政府特许经营税务局的注册会计师Audrey Rowe详细讲解了在加州和联邦政府两个层级获得非营利组织资格的不同申报表，以及不同的报税表格，同时介绍了年度财务状况申报的程序。特别提醒非营利组织也要每 两年向加州州务卿办公室申报财务报表以保持机构的的注册状态。
拥有超过一万多个会员的加州非营利组织协会的政策董事Nancy Berlin向到场的非营利机构代表介绍了，非营利组织要持续发展，必须要聘请专业人士运营，需要运营资本，非营利组织需要筹款，并可以向各类基金会和政府申请运营资金。有统计表示，投入在非营利组织的每一美元相当于投入在政府的七到八美元。所以，许多加州非营利组织的效率和声誉是有口皆碑的。
专门向公众提供法律援助服务的加州公共辩护律师机构（Public Consel）的律师Patrick Anderson介绍了非营利组织运营和筹款的法律注意事项。
经美国联邦国税局IRS核准的非营利组织全美中华青年联合会，属于在新侨社团中，较早和较为稀少的经联邦核准的非营利组织。参加工作坊的会长任向东表示，非营利组织一方面可以在税务方面享有免税资格，但是另一方面，则要接受较为严格的监管。但监管可以促进社团的规范和专业运营，进而确保社团的可持续发展。同时，随着新移民的快速增长，华裔的非营利组织目前应该有很大的拓展空间。
华人社团还是应该侧重于在地服务，不要给当地社会留下华人社团只是接待代表团和回国开会的印象。（AACYF洛杉矶讯）
星期一, 5月 01, 2017
世界醫療創新論壇1300人參加
 |
| 5家醫療公司執行長分享看法。(周菊子攝) |
(Boston
Orange周菊子波士頓報導)醫療夥伴(Partners HealthCare)公司主辦的世界醫療創新論壇(World
Medical Innovation Forum)，今年以心血管護理(cardiovascular
care) 為主題，從1日起，一連三日在波士頓衛斯汀(Westin)酒店舉行，共有1300人參加，125場演講及座談。
 |
| 夥伴醫療(Partner Health)執行長David Torchiana。(周菊子攝) |
夥伴醫療(Partner Health)執行長David Torchiana透露，明年這會議將以人工智能及其對醫療護理的影響為重點。
1日早上，在大會開幕前，由19名心血管護理領域新星，闡述他們各自可能改變心臟病研究及臨床醫療的新方法，以及商業化的可能，包括用生活型態來改變心臟病的基因危機，採用斑馬魚心血管疾病模式，或是運動來改善心臟表現等等。
 |
| 夥伴醫療(Partner Health)執行長David Torchiana。 |
其中4名新秀為華裔，包括以生物活性脂質譜來識別心臟病可能性的哈佛醫學院助理教授Susan Cheng，研究控制幹細胞新方法的哈佛醫學院助理教授方奕華，界定心臟代謝及肺動脈高壓的哈佛醫學院教職員暨麻州總醫院(MGH)助理醫師何思倩，研究傳導信號及肺血管疾病的哈佛醫學院副教授游博群。
 |
| 哈佛醫學院助理教授方奕華。(周菊子攝) |
1日的議程還包括七個分場座談，幾乎都談到創新在治療心臟病上對改良醫療效果，改善設備及診斷技術等的重要性，包括討論由新途徑來看心臟衰竭，到底甚麼才是醫療設備創新，有些甚麼障礙，未來十年的換心療法，在治療心臟病上以影像為基礎的人工智能應用，新的生物端點功能及結構，從供應者的角度來看付費方法，治療心臟病的可穿戴儀器如何整合進醫療體系中等。
例如，要改善壽命長度，減少使用心室輔助裝置的心臟衰竭病人出現併發症，就得改善設備。同樣的，能降低分子影像科技費用的新策略，有助於心臟疾病的成像，加速整合進個人化醫療的新治療方法發展等。
 |
| 麻州總醫院(MGH)助理醫師何思倩。(周菊子攝) |
電腦計算及處理能力的提升，最近已讓人對人工智能期待更高，如何找方法來把這方面的突破成就整合進新診斷儀器中，以及早知道快有心臟病了，仍然是個挑戰。
談到治療心臟病的費用管理上，出席者認為重點應該放在找出有價值的創新策略上，而不是一味地追求降低費用。設備及藥物能增加療效，卻不需要
 |
| 哈佛醫學院副教授，BWH醫師游博群。(周菊子攝) |
在布里吉罕及婦女醫院(BWH)心臟醫學主管Calum MacRae，麻州總醫院心臟組主管Anthony
Rosenzweig指出，心臟醫療是美國每年約斥資16億元研究的重要領域，針對個人，從病患實際需要來研擬醫療方案，以越來越受重視。
夥伴醫療(Partner Health)執行長David Torchiana在開幕致詞時指出，早在1968年，就有文獻指出心血管疾病，中風名列美國十大死因，如今也每年約有100萬人因此死亡，現有約5到9千萬人患有某種心血管疾病，或中風，從各方面來優化人們的身體健康，找出醫治，預防相關疾病的創新方法，已越來越重要。明年這會議將從人工智能角度來做探討。
 |
| Michael Minogue。 |
他和夥伴醫療學術長Anne Klibanski還重點提及心臟醫療上的多項重要議題，包括儀器發展，以及在管理心房顫動，心室衰竭，周邊動脈上的挑戰。
1日的會議焦點，還包括5名業界執行長的座談。通用電子(GE)醫療護理公司執行長John Flannery，Abiomed執行長Michael Minogue，Bard 執行長Timothy Ring，Edwards 生命科學執行長Michael Mussallem，聯合健康集團執行副總裁Lewis Sandy
等人在夥伴醫療創新部的客座主管Benjamin
Pless的訪談中，分享看法。
 |
| Timothy Ring。 |
在5月2日的議程中，墨克(Merck)轉化醫學副總裁 Dean Li是”精準心血管醫療:這次有什麼不同”這場座談的其中一名講者。
已跨入第三屆的這世界醫療創新論壇，將在波士頓市衛斯汀酒店一直進行至5月3日，醫療界高館雲集。(5/2/2017更新)
 |
| Michael Mussallem。 |
 |
| John Flannery。 |
 |
| Lewis Sandy。 |
波士頓台灣同鄉會健康講座談老人失智
 |
| 波士頓臺灣同鄉會會長謝富凱(左起)、前會長吳美芬、鄭又禎醫師與 波士頓僑教中心主任歐宏偉合影。(周菊子攝) |
 |
(Boston Orange周菊子牛頓市整理報導)波士頓臺灣同鄉會與波士頓臺灣基督教會4月30日下午在教會牛頓市會址舉辦健康講座，邀請亞東醫院神經內科醫師鄭又禎闡述「失智知多少」，約50餘人出席，發問踴躍。
 |
健康講座主講人鄭又禎醫師(前排中)與波士頓臺灣同鄉會會長謝富凱
(後排右一)、前會長吳美芬(前排右三)、波士頓僑教中心主任歐宏偉 (右二)，波士頓台灣人生物協會(BTBA)前會長王志傑(後左三)等人 合影。(周菊子攝) |
鄭又禎醫師從失智症的種類、成因、癥狀、診斷、治療及預防等層面分別做介紹，還說明各人可以如何自己辨識是否已患此症，平日該如何預防等等。她鼓勵大家多採取地中海式飲食，減少抽煙、飲酒等不良嗜好。對於家有失智症患者的人，她建議以迂迴方式相處，讓患者接受外來幫助。
駐波士頓臺北經濟文化辦事處副處長陳銘俊、波士頓僑教中心主任歐宏偉當天都出席了講座。歐宏偉還當面邀請鄭又禎擇日到波士頓僑教中心也辦一場這講座，幫助更多想要了解失智症的人。
波士頓台灣同鄉會會長，目前在麻州總醫院做研究的謝富凱，會末代鄭又禎醫師送出兩本相關書籍，並宣布該會下一個活動是慶祝母親節郊遊健走。
波士頓台灣同鄉會前會長吳美芳表示，該會和台灣人公共事務會(FAPA)新英格蘭分會都很幸運，找到年輕人接棒，有了傳承。
哈佛華人生命科學年會創業大賽(圖片)
 |
| 哈佛醫學院第二屆華人創業論壇評審與得獎人合影。(周菊子攝) |
 |
| 田曉宇(左)和蔣一得兩名評審兼講者和得獎人之一的胡小明(中)合影。(周菊子攝) |
 |
| 張靖。 |
 |
| 易庭芳獲第二名。 |
 |
| 啟迪公司副總經理Han Kai Yi (右)。(周菊子攝) |
医学院各位在创业路上的小伙伴们！
我们HMS-CSSA即将举办第二届创业论坛！
现诚邀感兴趣的朋友前来参加，机会不容错过！
活动介绍：随着新英格兰地区华人专家学者群体中创业的人数激增，哈佛医学院HMS-CSSA希望通过举办创业论坛和项目路演的形式为正在创业或者有创业打算的群体提供一个能够交流、学习和帮助的平台。此次论坛的目的在于为我们医学院的创业者提供一个与众多天使投资人深度接触的机会，并通过多方参与研讨，帮助创业者分析项目商业模式的可行性、评估项目的价值和制定最佳发展路线！
本次活动将评选出优秀路演项目，并给予奖励。
一等奖一名：1500美金+证书
二等奖一名：1000美金+证书
Last Calling: 感兴趣的同学请于4月26号前将创业项目简介 (300-500字，或slides) 发送至 CSSA@HMS-CSSA.ORG
时间： 04/30/2017 (星期日)
地点：Folkman Auditorium, Enders Building, Children’s Hospital Boston
320 Longwood Ave, Boston, MA 02155
活动安排：
9:00am-9:25am
Alan Jiang, PhD, Chief Strategy Officer, XtalPi
Title: TBD
9:25am-9:50am
Xiaoyu Tian, PhD, Vice President of Product Development, VcanBio
Title：Entrepreneurship in Medicine: Some Personal Lessons and Observations
9:50am-10:15am
Jeff Clark, J.D. & M.D. Associate at DLA Piper
Title: Intellectual Property Protection in USA
(Taking example of the gene editing Crispr/Cas9 patent)
10:15am-10:40am
Chesley Chen, CEO, Saftypartners, USA
Title: Zen and the Art of CEO Maintenance
10:40am-11:20am
Panel discussion
Chesley Chen(Modulator), Alan Jiang, Xiaoyu Tian, Jeff Clark
11:00am-12:40pm
项目路演（10 min presentation + 5 min Q&A）
12:40am-1:00pm:
Mr. Han-kai Yi, Vice General Manager, TusPark
Title: Global Talent for a Chinese Dream, Together Here for a Stronger
1:00 pm-1:10 pm
“哈佛医学院华人启迪爱创奖”颁奖典礼
(启迪控股赞助)
1:10 pm-2:00 pm:
午餐和自由交流
目前确认的受邀嘉宾包括: Tus-holdings （启迪控股）; Yongjin Group （涌金集团）；Legend Capital （君联资本）；CSC Group （中科招商）；Wuxi Healthcare Venture （毓承资本）；Simcere（先声药业）；GeneChem（吉凯基因）等等
演讲嘉宾简介：
Alan Jiang, PhD
Yide Alan Jiang oversees global market positioning and strategy development at XtalPi. Dr.Jiang has 14 years of experience in biopharmaceutical R&D, with expertise in managing external translational science collaborations between academia, industry and contract research organizations. Prior to joining XtalPi, Dr. Jiang held the role of Director of Asia R&D strategy and Associate Scientific Director at Genzyme, where he led cross-functional R&D collaborations and projects in Asia and conducted external consultation for various companies on R&D strategy and processes. His completed his postdoctoral fellowship of hematology and oncology at Harvard Medical School, and has worked as project manager at China’s National Institute for the Control of Pharmaceutical and Biological Products (NICPBP, NIFDC), CFDA.
Dr. Jiang earned his Ph.D. in molecular biology from University of Tennessee-Health Science Center and M.D. from Shanghai Medical University (now Shanghai Medical College of Fudan University).
Xiaoyu Tian, PhD
Dr. Xiaoyu Tian joined VcanBio Center for Translational Biotechnology Co. in 2017 as Vice President, Product Development and is responsible for advancing all in-house and partnered drug development programs. With more than 20 years experiences in drug discovery and development at both academic and industrial settings, Dr. Tian is a technical expert in the molecular/structural biophysics-guided drug discovery and nanoparticle design for targeted drug delivery. He was formerly a senior research investigator at Bristol-Myer-Squibb, where he contributed to anti-viral and immune-oncology programs. Dr. Tian was a serial entrepreneur in the development of a pipeline of medical imaging diagnostics/devices, and the concurrent development of therapeutical products. He served as co-founder and R&D director of Beijing Beilu Pharmaceuticals, co-founder and President of Essenix Pharmaceuticals and cofounder and President of ADetect Diagnostics. He has been a senior consultant to HitGen Ltd and involved in early work at BioHermes Technologies on the DEL and IVD technologies for pharmaceutical applications. He is also an adjunct faculty member at Center for Drug Discovery, Northeastern University, where he contributes to explore the science of medicinal implications of Cannabis and the function of human endocannabinoid system. He received his Ph.D. in Pharmaceutical Sciences from the University of Connecticut, his BS and MS degrees in Quantum Electronics from Peking University, and a NIH post-doctoral fellowship on drug abuse.
Jeff Clark, J.D.& M.D.
(Jeff is also among those drafted the ground breaking CRISPR/Cas9 gene editing patent.)
Jeff Clark, M.D., J.D. is an associate at DLA Piper with a focus on patent litigation and the defense of pharmaceutical, life science and medical device companies in a variety of cases, including multi-district product liability litigation. Jeff also concentrates his practice on all aspects of patent law including patent prosecution and strategic counseling for life science start-ups, biotech, medical device and pharmaceutical companies. Jeff has extensive clinical and basic science research experience. He was a clinical research fellow in the Molecular and Vascular Medicine Unit, Renal Division (Department of Medicine), at Beth Israel Deaconess Medical Center and in the Cardiovascular Research Center (Department of Cardiology) at Massachusetts General Hospital. Jeff has authored and co-authored several publications in peer-reviewed journals and has presented at the national American Society of Nephrology Renal Week conference.
Chesley Chen, CEO,
Chesley Chen is Chief Executive Officer of Safety Partners, Inc., which provides environmental, health, and safety programs to over 200 life science and technology companies each year. Chen is a serial entrepreneur and brings extensive experience in launching and scaling up early to mid-stage health technology, life science, and financial service ventures. He has over 30 years experience in executive management, corporate strategy, client service, product development, operations, technology, and finance. He has worked for a wide range of firms including Health Dialog, Good Measures, The Warner Babcock Institute for Green Chemistry, and Goldman Sachs.
Chen holds a BS in Civil Engineering from Tufts University, an SM in Aeronautics and Astronautics from MIT, and an MBA from the Harvard Business School. As he continues on his career journey, he dedicates time to sharing his experiences about his path to CEO and his ongoing learnings. Outside of work, he devotes his time to family, rock climbing, martial arts, piano, and studying the arts and sciences. He is of Chinese heritage, the son and grandson of Chinese immigrants.
Mr. Han-kai Yi
Han-kai Yi joined TusPark (Jiangsu) as Vice General Manager in 2014. He oversees the operation, corporate relationship, corporate innovation service and incubation departments for TusParks the Jiangsu, Anhui and Zhejiang provinces, as well as the Qingpu district of Shanghai. Mr Yi has over 10 years experience developing science and technology service facilities. He is an alumnus of Nanjing University
主办：哈佛医学院华人专家学者联合会（HMS-CSSA）
协办：纽英伦中华资讯网络协会（NECINA）
美中生物医药协会（CABA）
美中医药开发协会（SAPA）
訂閱：
文章 (Atom)